JP7331149B2 - 直腸および局所投与のためのゲル - Google Patents

直腸および局所投与のためのゲル Download PDF

Info

Publication number
JP7331149B2
JP7331149B2 JP2021572255A JP2021572255A JP7331149B2 JP 7331149 B2 JP7331149 B2 JP 7331149B2 JP 2021572255 A JP2021572255 A JP 2021572255A JP 2021572255 A JP2021572255 A JP 2021572255A JP 7331149 B2 JP7331149 B2 JP 7331149B2
Authority
JP
Japan
Prior art keywords
weight
parts
gel
poloxamer
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021572255A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022521444A (ja
JPWO2020176004A5 (enExample
Inventor
ルスタム ムニロヴィッチ イクサノフ、
アレキサンドル ヨシフォヴィチ ルツコ、
ボリス ボリソヴィチ シスエフ、
Original Assignee
ノヴァメディカ リミテッド ライアビリティー カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノヴァメディカ リミテッド ライアビリティー カンパニー filed Critical ノヴァメディカ リミテッド ライアビリティー カンパニー
Publication of JP2022521444A publication Critical patent/JP2022521444A/ja
Publication of JPWO2020176004A5 publication Critical patent/JPWO2020176004A5/ja
Application granted granted Critical
Publication of JP7331149B2 publication Critical patent/JP7331149B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2021572255A 2019-02-25 2019-02-25 直腸および局所投与のためのゲル Active JP7331149B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2019/000120 WO2020176004A1 (ru) 2019-02-25 2019-02-25 Гель для ректального и наружного применения

Publications (3)

Publication Number Publication Date
JP2022521444A JP2022521444A (ja) 2022-04-07
JPWO2020176004A5 JPWO2020176004A5 (enExample) 2022-11-28
JP7331149B2 true JP7331149B2 (ja) 2023-08-22

Family

ID=72235046

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021572255A Active JP7331149B2 (ja) 2019-02-25 2019-02-25 直腸および局所投与のためのゲル

Country Status (3)

Country Link
JP (1) JP7331149B2 (enExample)
EA (1) EA036752B1 (enExample)
WO (1) WO2020176004A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022252406A1 (en) * 2021-04-01 2023-11-02 Steel Therapeutics, Inc. Topical wipe containing nifedipine and lidocaine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1813766A (zh) 2005-12-19 2006-08-09 杨树强 一种痔疮软膏及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1297886B1 (it) * 1997-02-28 1999-12-20 Carmine Antropoli Nifedipina per uso topico
RU2538079C1 (ru) * 2013-12-30 2015-01-10 Светлана Николаевна Суслина Композиция для лечения анальных трещин
RU2606858C2 (ru) * 2014-09-30 2017-01-10 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" Способ растворения нифедипина в водной среде с использованием нанотехнологии. фармацевтическая композиция, содержащая раствор нифедипина в водной среде. способ количественного определения нифедипина в растворе
RU2641570C2 (ru) * 2015-01-21 2018-01-18 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" Гель, включающий нифедипин и лидокаина гидрохлорид (варианты), применение геля, включающего нифедипин и лидокаина гидрохлорид (варианты), способ приготовления геля, включающего нифедипин и лидокаина гидрохлорид, с использованием нанотехнологии
WO2016118040A1 (ru) * 2015-01-21 2016-07-28 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" Гель, содержащий нифедипин и лидокаина гидрохлорид, его применение и способ приготовления с использованием нанотехнологий

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1813766A (zh) 2005-12-19 2006-08-09 杨树强 一种痔疮软膏及其制备方法

Also Published As

Publication number Publication date
EA036752B1 (ru) 2020-12-16
JP2022521444A (ja) 2022-04-07
WO2020176004A1 (ru) 2020-09-03
EA201991220A1 (ru) 2020-08-31

Similar Documents

Publication Publication Date Title
JP5118633B2 (ja) 医療用デバイスおよび医薬製剤において有用な粘膜付着性キシログルカン含有製剤
EP2034956B1 (en) Compositions comprising glycosaminoglycans of low viscosity and use of said composition in therapy of chronic cystitis
BR122014001142A2 (pt) Formulação purgativa colônica, kit, método de purgar o cólon de um paciente, e, processo de produzir a formulação purgativa colônica
JP6117939B2 (ja) ジクロフェナク組成物
DE69906302T2 (de) Arzneimittel insbesondere zur vorbeugung und behandlung von strahlungs- und chemomukositiden
US12336979B2 (en) Material and method for treating cancer
JP7331149B2 (ja) 直腸および局所投与のためのゲル
JP2018521139A (ja) 急速な作用発現を得るための発作の治療における口腔投与のためのミダゾラム組成物
JP2022173353A (ja) 注腸剤
RU2538079C1 (ru) Композиция для лечения анальных трещин
IT201800002413A1 (it) "composizione a base di nifedipina per uso nel trattamento delle ragadi anali e proctalgie"
JPWO2020176004A5 (enExample)
CN103635194B (zh) 用于治疗早泄的药物组合物以及用于治疗早泄的方法
JP2022537460A (ja) キシログルカン及びアルコールを含む、活性成分の制御放出のためのゲル形態の医薬組成物
CN106309354A (zh) 一种含酮咯酸氨丁三醇的鼻腔给药温度敏感性原位凝胶缓释制剂
CN109999022B (zh) 一种外科术后护理抗炎药物及其制备方法
CN111163756A (zh) 氯普鲁卡因的局部制剂
US6693100B1 (en) Pharmaceutical compositions for treating psoriasis
JP2012525359A (ja) イブプロフェンリシナートの経口投与用の懸濁液
US7645765B2 (en) Use of moxaverin for treating erectile dysfunction, forms of dementia or diseases associated to an arteriosclerotic occlusion
RU2323721C2 (ru) Местноанестезирующее и антисептическое средство
TR2022007389A2 (tr) Topi̇kal formülasyonlar
EP1884241A1 (en) A oral preparation comprising dyclonine hydrochloride
CN105560248A (zh) 一种治疗真菌感染的药物组合物及其制备方法和应用
CN116392486A (zh) 一种防治缺血性脑卒中的药物组合物及其应用

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210922

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220830

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20221117

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230110

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230407

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230711

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230809

R150 Certificate of patent or registration of utility model

Ref document number: 7331149

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150